Lyc Healthcare Bhd Stock Current Valuation
| 0075 Stock | 0.09 0.01 5.88% |
Valuation analysis of Lyc Healthcare Bhd helps investors to measure Lyc Healthcare's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Lyc Healthcare's price fluctuation is out of control at this time. Calculation of the real value of Lyc Healthcare Bhd is based on 3 months time horizon. Increasing Lyc Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Lyc stock is determined by what a typical buyer is willing to pay for full or partial control of Lyc Healthcare Bhd. Since Lyc Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Lyc Stock. However, Lyc Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.09 | Real 0.0777 | Hype 0.09 | Naive 0.0905 |
The intrinsic value of Lyc Healthcare's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Lyc Healthcare's stock price.
Estimating the potential upside or downside of Lyc Healthcare Bhd helps investors to forecast how Lyc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Lyc Healthcare more accurately as focusing exclusively on Lyc Healthcare's fundamentals will not take into account other important factors: Lyc Healthcare Bhd Company Current Valuation Analysis
Lyc Healthcare's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Lyc Healthcare Current Valuation | 223.45 M |
Most of Lyc Healthcare's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lyc Healthcare Bhd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Lyc Healthcare Bhd has a Current Valuation of 223.45 M. This is 98.44% lower than that of the Healthcare sector and significantly higher than that of the Healthcare Providers & Services industry. The current valuation for all Malaysia stocks is 98.66% higher than that of the company.
Lyc Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lyc Healthcare's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Lyc Healthcare could also be used in its relative valuation, which is a method of valuing Lyc Healthcare by comparing valuation metrics of similar companies.Lyc Healthcare is rated fourth in current valuation category among its peers.
Lyc Fundamentals
| Return On Equity | -36.93 | |||
| Current Valuation | 223.45 M | |||
| Price To Book | 3.07 X | |||
| Price To Sales | 1.52 X | |||
| Revenue | 64.6 M | |||
| EBITDA | 15.14 M | |||
| Net Income | (1.22 M) | |||
| Total Debt | 118.9 M | |||
| Cash Flow From Operations | 344 K | |||
| Market Capitalization | 121.77 M | |||
| Total Asset | 183.18 M | |||
| Z Score | 0.6 | |||
| Net Asset | 183.18 M |
About Lyc Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Lyc Healthcare Bhd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lyc Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lyc Healthcare Bhd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Lyc Stock
Lyc Healthcare financial ratios help investors to determine whether Lyc Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lyc with respect to the benefits of owning Lyc Healthcare security.